China Pioneer Pharma Holdings Limited provided earnings guidance for the six months ended June 30, 2020. Based on the preliminary review of the management accounts of the group for the reporting period and the information currently available, the Group is expected to record a decrease in net profit of approximately 60% to 70% in the Reporting Period as compared with the corresponding period last year.